Evidence map›Paper›PMID 27748080›Full record

ArticleCancer medicine2016

Variants in autophagy-related genes and clinical characteristics in melanoma: a population-based study.

Kirsten A M White, Li Luo, Todd A Thompson, Salina Torres, Chien-An Andy Hu, Nancy E Thomas, Jenna Lilyquist, Hoda Anton-Culver, Stephen B Gruber, Lynn From and 12 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pathogenic Single Nucleotide Polymorphisms on Autophagy-Related Genes.International journal of molecular sciences · 2020
    Review
  9. Non-Apoptotic Cell Death Signaling Pathways in Melanoma.International journal of molecular sciences · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 5 countries.

Kirsten A M WhiteDepartment of Medicine, Division of Epidemiology, University of New Mexico, Albuquerque, New Mexico.
Li LuoDepartment of Medicine, Division of Epidemiology, University of New Mexico, Albuquerque, New Mexico.
Todd A ThompsonDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico.
Salina TorresCenter for HPV Prevention, Department of Pathology University of New Mexico, Albuquerque, New Mexico.
Chien-An Andy HuDepartment of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, New Mexico.
Nancy E ThomasDepartment of Dermatology, University of North Carolina, Chapel Hill, North Carolina.
Jenna LilyquistDepartment of Medicine, Division of Epidemiology, University of New Mexico, Albuquerque, New Mexico.
Hoda Anton-CulverDepartment of Epidemiology, School of Medicine, University of California, Irvine, California.
Stephen B GruberDepartment of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
Lynn FromCancer Care Ontario, Toronto, Ontario, Canada.
Klaus J BusamDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Irene OrlowDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Peter A KanetskyDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.
Loraine D MarrettCancer Care Ontario, Toronto, Ontario, Canada.
Richard P GallagherBritish Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Lidia SacchettoPiedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, Turin, Italy.
Stefano RossoPiedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, Turin, Italy.
Terence DwyerGeorge Institute for Global Health, University of Oxford, UK.
Anne E CustUniversity of Sydney, Sydney, New South Wales, Australia.
Colin B BeggDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Marianne BerwickDepartment of Medicine, Division of Epidemiology, University of New Mexico, Albuquerque, New Mexico.
GEM Study Group
University of New Mexico · USMemorial Sloan Kettering Cancer Center · USCancer Care Ontario · CAPiedmont Reference Center for Epidemiology and Cancer Prevention · ITBC Cancer Agency · CAGeorge Institute for Global Health · GBMoffitt Cancer Center · USUniversity of California, Irvine · USUniversity of North Carolina at Chapel Hill · USUniversity of Southern California · USUniversity of Sydney · AU

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
FAIR Data Competency and Machine Learning Readiness for Biomedical ScientistsK12GM088021 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI REBECCA S. HARTLEY, Diane Lidke · 2009 to 2026
$16.4M
University of New Mexico Clinical and Translational Science CenterUL1TR000041 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LARSON, RICHARD S · 2012 to 2014
$9.8M
Melanoma RAS/BRAF Mutation:Heterogeneity-Risk-PrognosisR01CA112243 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THOMAS, NANCY E. · 2005 to 2014
$5.4M
Mayo Cancer Genetic Epidemiology Training ProgramR25CA092049 · NCI · MAYO CLINIC ROCHESTER · PI PETERSEN, GLORIA M., VACHON, CELINE M · 2001 to 2018
$5.3M
A MODEL FOR GENETIC SUSCEPTIBILITY: MELANOMAU01CA083180 · NCI · UNIVERSITY OF NEW MEXICO · PI BERWICK, MARIANNE · 1999 to 2003
$5.2M
Solar Exposure and Melanoma SurvivalR01CA112524 · NCI · UNIVERSITY OF NEW MEXICO · PI BERWICK, MARIANNE · 2005 to 2009
$2.5M
Melanoma NRAS/BRAF Mutations: A Population-Based StudyK07CA102096 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THOMAS, NANCY E · 2003 to 2007
$650k
NCATS NIH HHS UL1 TR000041NCI NIH HHS K07 CA102096NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA112243NCI NIH HHS R01 CA112524NCI NIH HHS R25 CA092049NCI NIH HHS U01 CA083180NIEHS NIH HHS P30 ES010126NIGMS NIH HHS K12 GM088021
6 · The paper itself

Abstract

Autophagy has been linked with melanoma risk and survival, but no polymorphisms in autophagy-related (ATG) genes have been investigated in relation to melanoma progression. We examined five single-nucleotide polymorphisms (SNPs) in three ATG genes (ATG5; ATG10; and ATG16L) with known or suspected impact on autophagic flux in an international population-based case-control study of melanoma. DNA from 911 melanoma patients was genotyped. An association was identified between (GG) (rs2241880) and earlier stage at diagnosis (OR 0.47; 95% Confidence Intervals (CI) = 0.27-0.81, P = 0.02) and a decrease in Breslow thickness (P = 0.03). The ATG16L heterozygous genotype (AG) (rs2241880) was associated with younger age at diagnosis (P = 0.02). Two SNPs in ATG5 were found to be associated with increased stage (rs2245214 CG, OR 1.47; 95% CI = 1.11-1.94, P = 0.03; rs510432 CC, OR 1.84; 95% CI = 1.12-3.02, P = 0.05). Finally, we identified inverse associations between ATG5 (GG rs2245214) and melanomas on the scalp or neck (OR 0.20, 95% CI = 0.05-0.86, P = 0.03); ATG10 (CC) (rs1864182) and brisk tumor infiltrating lymphocytes (TILs) (OR 0.42; 95% CI = 0.21-0.88, P = 0.02), and ATG5 (CC) (rs510432) with nonbrisk TILs (OR 0.55; 95% CI = 0.34-0.87, P = 0.01). Our data suggest that ATG SNPs might be differentially associated with specific host and tumor characteristics including age at diagnosis, TILs, and stage. These associations may be critical to understanding the role of autophagy in cancer, and further investigation will help characterize the contribution of these variants to melanoma progression.

Indexed as

Genetic Predisposition to DiseaseGenetic VariationPopulation SurveillanceAdultAgedAllelesAutophagyAutophagy-Related ProteinsFemaleGenotypeHumansMaleMelanomaMiddle AgedModels, BiologicalNeoplasm StagingATG16L1 protein, humanAutophagy-Related ProteinsATG16L1autophagymelanomapolymorphismSNP

Identifiers

PMID27748080
PMCPMC5119988
OpenAlexW2535993440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.